GRAIL’s new REACH study of Galleri MCED test set to change future of cancer detection for seniors – Find out how
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company renowned for its mission to detect cancer early when it can be effectively treated, has announced a significant milestone in its pursuit of advancing early cancer detection. The first participant has been enrolled in the groundbreaking Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity (REACH/Galleri-Medicare) study at […]
